Page 22 - 80_02
P. 22
Development
of
anti--Leishmania
vaccines…
54
Carmelo,
E.;
Zurita,
A.
I.;
Martinez,
E.;
Valladares,
B.
The
sera
from
individuals
suffering
from
cutaneous
leishmaniasis
due
to
Leishmania
brazilensis
present
antibodies
against
parasitic
conserved
proteins,
but
not
their
human
counterparts.
Parasite
13,
231--236
(2006).
55
Carmelo,
E.;
Martinez,
E.;
Gonzalez,
A.
C.;
Pinero,
J.
E.;
Patarroyo,
M.
E.;
Del
Castillo,
A.;
Valladares,
B.
Antigenicity
of
Leishmania
braziliensis
histone
H1
during
cutaneous
leishmaniasis:
localization
of
antigenic
determinants.
Clinical
and
Diagnostic
Laboratory
Immunology
9,
808--811(2002).
56
Soto,
M.;
Requena,
J.
M.;
Quijada,
L.;
Garcia,
M.;
Guzman,
F.;
Patarroyo,
M.
E.;
Alonso,
C.
Mapping
of
the
linear
antigenic
determinants
from
the
Leishmania
infantum
histone
H2A
recognized
by
sera
from
dogs
with
leishmaniasis.
Immunology
Letters
48,
209--214
(1995).
57
Soto,
M.;
Requena,
J.
M.;
Quijada,
L.;
Gomez,
L.
C.;
Guzman,
F.;
Patarroyo,
M.
E.;
Alonso,
C.
Characterization
of
the
antigenic
determinants
of
the
Leishmania
infantum
histone
H3
recognized
by
antibodies
elicited
during
canine
visceral
leishmaniasis.
Clinical
and
Experimental
Immunology
106,
454--461(1996).
58
Meddeb--Garnaoui,
A.;
Toumi,
A.;
Ghelis,
H.;
Mahjoub,
M.;
Louzir,
H.;
Chenik,
M.
Cellular
and
humoral
responses
induced
by
Leishmania
histone
H2B
and
its
divergent
and
conserved
parts
in
cutaneous
and
visceral
leishmaniasis
patients,
respectively.
Vaccine
28,
1881--
1886
(2010).
59
de
Carvalho,
L.
P.;
Soto,
M.;
Jeronimo,
S.;
Dondji,
B.;
Bacellar,
O.;
Luz,
V.;
Orge,
G.;
Alonso,
C.;
Jesus,
A.
R.;
Carvalho,
E.
M.
Characterization
of
the
immune
response
to
Leishmania
infantum
recombinant
antigens.
Microbes
and
Infection
5,
7--12
(2003).
60
Iborra,
S.;
Soto;
M.;
Carrion,
J.;
Alonso,
C.;
Requena,
J.
M.
Vaccination
with
a
plasmid
DNA
cocktail
encoding
the
nucleosomal
histones
of
Leishmania
confers
protection
against
murine
cutaneous
leishmaniosis.
Vaccine
22,
3865--3876
(2004).
61
Carrion,
J.;
Nieto,
A.;
Soto,
M.;
Alonso,
C.
Adoptive
transfer
of
dendritic
cells
pulsed
with
Leishmania
infantum
nucleosomal
histones
confers
protection
against
cutaneous
leishmaniosis
in
BALB/c
mice.
Microbes
and
Infection
9,
735--743
(2007).
62
Carneiro,
M.
W.;
Santos,
D.
M.;
Fukutani,
K.
F.;
Clarencio,
J.;
Miranda,
J.
C.;
Brodskyn,
C.;
Barral,
A.;
Barral--Netto,
M.;
Soto,
M.;
de
Oliveira,
C.
I.
Vaccination
with
L.
infantum
chagasi
nucleosomal
histones
confers
protection
against
new
world
cutaneous
leishmaniasis
caused
by
Leishmania
braziliensis.
PLoS
One.
7,
e52296
(2012).
63
Carrion,
J.;
Folgueira,
C.;
Alonso,
C.
Immunization
strategies
against
visceral
leishmaniosis
with
the
nucleosomal
histones
of
Leishmania
infantum
encoded
in
DNA
vaccine
or
pulsed
in
dendritic
cells.
Vaccine
26,
2537--44
(2008).
64
Solioz,
N.;
Blum--Tirouvanziam,
U.;
Jacquet,
R.;
Rafati,
S.;
Corradin,
G.;
Mauel,
J.;
Fasel,
N.
The
protective
capacities
of
histone
H1
against
experimental
murine
cutaneous
leishmaniasis.
Vaccine.
18,
850--859
(1999).
65
Masina,
S.;
Gicheru,
M.
M.;
Demotz,
S.
O.;
Fasel,
N.
J.
Protection
against
cutaneous
leishmaniasis
in
outbred
vervet
monkeys
using
a
recombinant
histone
H1
antigen.
The
Journal
of
Infectious
Diseases.
188,
1250--1257
(2003).
66
Moreno,
J.;
Nieto,
J.;
Masina,
S.;
Cañavate,
C.;
Cruz,
I.;
Chicharro,
C.;
Carrillo,
E.;
Napp,
S.;
Reymond,
C.;
Kaye,
P.
M.;
Smith,
D.
F.;
Fasel,
N.;
Alvar,
J.
Immunization
with
H1,
HASPB1
and
MML
Leishmania
proteins
in
a
vaccine
trial
against
experimental
canine
leishmaniasis.
Vaccine
25,
5290--5300
(2007).
67
Coelho,
E.
A.;
Ramirez,
L.;
Costa,
M.
A.;
Coelho,
V.
T.;
Martins,
V.
T.;
Chavez--Fumagalli,
M.
A.;
Oliveira,
D.
M.;
Tavares,
C.
A.;
Bonay,
P.;
Nieto,
C.
G.;
Abanades,
D.
R.;
Alonso,
C.;
Soto,
M.
Specific
serodiagnosis
of
canine
visceral
leishmaniasis
using
Leishmania
species
ribosomal
protein
extracts.
Clinical
and
Vaccine
Immunology
16,
1774--1780
(2009).
68
Ramirez,
L.;
Santos,
D.
M.;
Souza,
A.
P.;
Coelho,
E.
A.;
Barral,
A.;
Alonso,
C.;
Escutia,
M.
R.;
Bonay,
P.;
de
Oliveira,
C.
I.;
Soto,
M.
Evaluation
of
immune
responses
and
analysis
of
the
effect
of
vaccination
of
the
Leishmania
major
recombinant
ribosomal
proteins
L3
or
L5
in
two
different
murine
models
of
cutaneous
leishmaniasis.
Vaccine.
31,
1312--1319
(2013).
69
Soto,
M.;
Requena,
J.
M.;
Quijada,
L.;
Angel,
S.
O.;
Gomez,
L.
C.;
Guzman,
F.;
Patarroyo,
M.
E.;
Alonso,
C.
During
active
viscerocutaneous
leishmaniasis
the
anti--P2
humoral
response
is
specifically
triggered
by
the
parasite
P
proteins.
Clinical
and
Experimental
Immunology
100,
246--252
(1995).
261